Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9958749 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TDP1EPHX1SMN1; SMN2SPHK2 | |
| SCHEMBL28726553 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TDP1EPHX1SMN1; SMN2SPHK2 | |
| SCHEMBL7031909 | 0.76 | — | — | |
| SCHEMBL28636169 | 0.73 | SMN1; SMN2 (0.42) | ALDH1A1TDP1EPHX1SMN1; SMN2SPHK2 | |
| SCHEMBL5183836 | 0.73 | EPHX1 (0.37) | ALDH1A1TDP1EPHX1 | |
| SCHEMBL3748950 | 0.73 | ALDH1A1 (0.31) | ALDH1A1TDP1SMN1; SMN2 | |
| SCHEMBL20240978 | 0.71 | EPHX1 (0.40) | ALDH1A1TDP1EPHX1 | |
| SCHEMBL11206443 | 0.71 | EPHX1 (0.36) | ALDH1A1TDP1EPHX1 | |
| SCHEMBL21522637 | 0.71 | EPHX1 (0.40) | ALDH1A1TDP1EPHX1 | |
| SCHEMBL29233375 | 0.71 | EPHX1 (0.40) | ALDH1A1TDP1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6767982-B2 | REACTING IN A FIRST STAGE AN ORGANOTRICHLOROSILANE OR A MIXTURE, WATER AND AN ALCOHOL AT 0-150 DEGREES C.; HYDROGEN CHLORIDE PRODUCT REMOVED; CRUDE PRODUCT TRANSFERRED TO REACTION DISTILLATION COLUMN; BOTTOMS RECOVERED | DEGUSSA AG (DE) | 2004-07-27 | — | — | US | disclosed |
| US-20020086907-A1 | Continuous manufacturing process for organoalkoxysiloxanes | DEGUSSA AG (DE) | 2002-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086907-A1 | Continuous manufacturing process for organoalkoxysiloxanes | MED1, C9, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 2070/4885TDP1 3912/4885EPHX1 906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.